

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of relaxation of muscle (GO:1901077) | 7.51976788 |
| 2 | response to muscle activity (GO:0014850) | 6.17095614 |
| 3 | response to inactivity (GO:0014854) | 5.51746768 |
| 4 | actomyosin structure organization (GO:0031032) | 5.36919378 |
| 5 | skeletal muscle fiber development (GO:0048741) | 5.34713897 |
| 6 | muscle contraction (GO:0006936) | 5.20568476 |
| 7 | regulation of cell communication by electrical coupling (GO:0010649) | 5.08497987 |
| 8 | muscle filament sliding (GO:0030049) | 4.95693540 |
| 9 | actin-myosin filament sliding (GO:0033275) | 4.95693540 |
| 10 | regulation of actin filament-based movement (GO:1903115) | 4.92764405 |
| 11 | myotube cell development (GO:0014904) | 4.92359865 |
| 12 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.89442841 |
| 13 | regulation of skeletal muscle contraction (GO:0014819) | 4.79344440 |
| 14 | cardiac muscle hypertrophy (GO:0003300) | 4.74537005 |
| 15 | carnitine shuttle (GO:0006853) | 4.70024867 |
| 16 | muscle system process (GO:0003012) | 4.66331702 |
| 17 | fatty acid transmembrane transport (GO:1902001) | 4.60635584 |
| 18 | striated muscle hypertrophy (GO:0014897) | 4.51741684 |
| 19 | lysine metabolic process (GO:0006553) | 4.39240592 |
| 20 | lysine catabolic process (GO:0006554) | 4.39240592 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.36883069 |
| 22 | L-phenylalanine catabolic process (GO:0006559) | 4.36093912 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.36093912 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 4.35634617 |
| 25 | muscle fiber development (GO:0048747) | 4.30451860 |
| 26 | skeletal muscle tissue development (GO:0007519) | 4.29410551 |
| 27 | NADH metabolic process (GO:0006734) | 4.27672014 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.20975146 |
| 29 | L-phenylalanine metabolic process (GO:0006558) | 4.20975146 |
| 30 | 2-oxoglutarate metabolic process (GO:0006103) | 4.17133549 |
| 31 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.16029500 |
| 32 | glycogen catabolic process (GO:0005980) | 4.15666039 |
| 33 | muscle cell cellular homeostasis (GO:0046716) | 4.11607122 |
| 34 | muscle tissue morphogenesis (GO:0060415) | 4.09441109 |
| 35 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.09434906 |
| 36 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.09170194 |
| 37 | actin-mediated cell contraction (GO:0070252) | 4.08573691 |
| 38 | striated muscle adaptation (GO:0014888) | 4.00421194 |
| 39 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.00295996 |
| 40 | muscle hypertrophy (GO:0014896) | 3.96620894 |
| 41 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.96544124 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.96098480 |
| 43 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.95561590 |
| 44 | glucan catabolic process (GO:0009251) | 3.92457397 |
| 45 | regulation of the force of heart contraction (GO:0002026) | 3.89265606 |
| 46 | regulation of striated muscle contraction (GO:0006942) | 3.88640282 |
| 47 | glyoxylate metabolic process (GO:0046487) | 3.85787872 |
| 48 | cardiac muscle cell development (GO:0055013) | 3.84607477 |
| 49 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.83595776 |
| 50 | aspartate family amino acid catabolic process (GO:0009068) | 3.83257940 |
| 51 | tricarboxylic acid cycle (GO:0006099) | 3.82733168 |
| 52 | sarcomere organization (GO:0045214) | 3.82268237 |
| 53 | kynurenine metabolic process (GO:0070189) | 3.81037733 |
| 54 | aromatic amino acid family catabolic process (GO:0009074) | 3.79410242 |
| 55 | adult heart development (GO:0007512) | 3.77665151 |
| 56 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.76380475 |
| 57 | muscle cell fate commitment (GO:0042693) | 3.75081052 |
| 58 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.74406606 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 3.70543671 |
| 60 | fatty acid beta-oxidation (GO:0006635) | 3.70049535 |
| 61 | bile acid biosynthetic process (GO:0006699) | 3.68477283 |
| 62 | * glycogen biosynthetic process (GO:0005978) | 3.68039391 |
| 63 | * glucan biosynthetic process (GO:0009250) | 3.68039391 |
| 64 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.66833951 |
| 65 | cellular polysaccharide catabolic process (GO:0044247) | 3.65474232 |
| 66 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.63037412 |
| 67 | amino-acid betaine metabolic process (GO:0006577) | 3.61352999 |
| 68 | sulfur amino acid catabolic process (GO:0000098) | 3.60797720 |
| 69 | regulation of triglyceride catabolic process (GO:0010896) | 3.60477643 |
| 70 | carnitine transmembrane transport (GO:1902603) | 3.59497068 |
| 71 | cardiac cell development (GO:0055006) | 3.58996892 |
| 72 | muscle structure development (GO:0061061) | 3.58480702 |
| 73 | muscle organ development (GO:0007517) | 3.57512424 |
| 74 | striated muscle cell development (GO:0055002) | 3.56857660 |
| 75 | regulation of sequestering of triglyceride (GO:0010889) | 3.55299132 |
| 76 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.54825453 |
| 77 | acetyl-CoA metabolic process (GO:0006084) | 3.53576255 |
| 78 | valine metabolic process (GO:0006573) | 3.51257024 |
| 79 | positive regulation of fatty acid oxidation (GO:0046321) | 3.50099783 |
| 80 | skeletal muscle tissue regeneration (GO:0043403) | 3.49842857 |
| 81 | complement activation, alternative pathway (GO:0006957) | 3.48503879 |
| 82 | fructose metabolic process (GO:0006000) | 3.48188730 |
| 83 | myofibril assembly (GO:0030239) | 3.47244396 |
| 84 | polysaccharide catabolic process (GO:0000272) | 3.42559425 |
| 85 | fatty acid oxidation (GO:0019395) | 3.40407832 |
| 86 | lipid oxidation (GO:0034440) | 3.40234428 |
| 87 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.38409328 |
| 88 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.38409328 |
| 89 | short-chain fatty acid metabolic process (GO:0046459) | 3.38098379 |
| 90 | cysteine metabolic process (GO:0006534) | 3.37450266 |
| 91 | indole-containing compound catabolic process (GO:0042436) | 3.37019956 |
| 92 | indolalkylamine catabolic process (GO:0046218) | 3.37019956 |
| 93 | tryptophan catabolic process (GO:0006569) | 3.37019956 |
| 94 | skeletal muscle contraction (GO:0003009) | 3.36362567 |
| 95 | carnitine transport (GO:0015879) | 3.35857341 |
| 96 | amino-acid betaine transport (GO:0015838) | 3.35857341 |
| 97 | fatty acid catabolic process (GO:0009062) | 3.35376985 |
| 98 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.35184884 |
| 99 | regulation of protein activation cascade (GO:2000257) | 3.34584663 |
| 100 | gluconeogenesis (GO:0006094) | 3.34174047 |
| 101 | branched-chain amino acid catabolic process (GO:0009083) | 3.33367651 |
| 102 | high-density lipoprotein particle remodeling (GO:0034375) | 3.33123934 |
| 103 | regulation of fatty acid oxidation (GO:0046320) | 3.31719863 |
| 104 | myoblast fusion (GO:0007520) | 3.31557648 |
| 105 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.31512170 |
| 106 | muscle hypertrophy in response to stress (GO:0003299) | 3.31512170 |
| 107 | cardiac muscle adaptation (GO:0014887) | 3.31512170 |
| 108 | negative regulation of protein localization to cell surface (GO:2000009) | 3.31504530 |
| 109 | relaxation of muscle (GO:0090075) | 3.30607889 |
| 110 | regulation of myoblast differentiation (GO:0045661) | 3.30519390 |
| 111 | creatine metabolic process (GO:0006600) | 3.29423992 |
| 112 | alpha-amino acid catabolic process (GO:1901606) | 3.29122613 |
| 113 | homocysteine metabolic process (GO:0050667) | 3.27270125 |
| 114 | glutamate metabolic process (GO:0006536) | 3.27195044 |
| 115 | striated muscle contraction (GO:0006941) | 3.26867379 |
| 116 | succinate metabolic process (GO:0006105) | 3.26102012 |
| 117 | carnitine metabolic process (GO:0009437) | 3.25861039 |
| 118 | positive regulation of myotube differentiation (GO:0010831) | 3.25774605 |
| 119 | striated muscle atrophy (GO:0014891) | 3.25733246 |
| 120 | plasma lipoprotein particle remodeling (GO:0034369) | 3.23415038 |
| 121 | protein-lipid complex remodeling (GO:0034368) | 3.23415038 |
| 122 | macromolecular complex remodeling (GO:0034367) | 3.23415038 |
| 123 | serine family amino acid catabolic process (GO:0009071) | 3.22085117 |
| 124 | monocarboxylic acid catabolic process (GO:0072329) | 3.22053329 |
| 125 | cardiac muscle contraction (GO:0060048) | 3.21591564 |
| 126 | * glycogen metabolic process (GO:0005977) | 3.20774229 |
| 127 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.20186028 |
| 128 | plasma membrane repair (GO:0001778) | 3.20131020 |
| 129 | cardiac myofibril assembly (GO:0055003) | 3.17203621 |
| 130 | negative regulation of fibrinolysis (GO:0051918) | 3.16789370 |
| 131 | ketone body metabolic process (GO:1902224) | 3.16275529 |
| 132 | response to activity (GO:0014823) | 3.15952323 |
| 133 | regulation of complement activation (GO:0030449) | 3.15532458 |
| 134 | striated muscle tissue development (GO:0014706) | 3.15282457 |
| 135 | cellular modified amino acid catabolic process (GO:0042219) | 3.15157256 |
| 136 | cellular amino acid catabolic process (GO:0009063) | 3.14256373 |
| 137 | muscle adaptation (GO:0043500) | 3.13655296 |
| 138 | heart contraction (GO:0060047) | 3.13572798 |
| 139 | heart process (GO:0003015) | 3.13572798 |
| 140 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.13343159 |
| 141 | * glucan metabolic process (GO:0044042) | 3.12949905 |
| 142 | * cellular glucan metabolic process (GO:0006073) | 3.12949905 |
| 143 | tryptophan metabolic process (GO:0006568) | 3.12767506 |
| 144 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.12620971 |
| 145 | muscle cell development (GO:0055001) | 3.12545362 |
| 146 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.12406811 |
| 147 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.12406811 |
| 148 | urea cycle (GO:0000050) | 3.11847736 |
| 149 | urea metabolic process (GO:0019627) | 3.11847736 |
| 150 | skeletal muscle adaptation (GO:0043501) | 3.11712544 |
| 151 | reverse cholesterol transport (GO:0043691) | 3.10543237 |
| 152 | protein carboxylation (GO:0018214) | 3.09542562 |
| 153 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.09542562 |
| 154 | actin filament-based movement (GO:0030048) | 3.08824237 |
| 155 | fatty acid homeostasis (GO:0055089) | 3.08482655 |
| 156 | branched-chain amino acid metabolic process (GO:0009081) | 3.07882444 |
| 157 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.07853158 |
| 158 | regulation of muscle system process (GO:0090257) | 3.07169268 |
| 159 | coenzyme catabolic process (GO:0009109) | 3.07042202 |
| 160 | acylglycerol homeostasis (GO:0055090) | 3.06514076 |
| 161 | triglyceride homeostasis (GO:0070328) | 3.06514076 |
| 162 | ethanol oxidation (GO:0006069) | 3.06357157 |
| 163 | biotin metabolic process (GO:0006768) | 3.05349165 |
| 164 | regulation of fibrinolysis (GO:0051917) | 3.05067412 |
| 165 | positive regulation of myoblast differentiation (GO:0045663) | 2.98396031 |
| 166 | hexose biosynthetic process (GO:0019319) | 2.97786855 |
| 167 | myotube differentiation (GO:0014902) | 2.97159295 |
| 168 | positive regulation of cation channel activity (GO:2001259) | 2.95071888 |
| 169 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.91658564 |
| 170 | regulation of muscle contraction (GO:0006937) | 2.90862378 |
| 171 | muscle atrophy (GO:0014889) | 2.90078553 |
| 172 | muscle organ morphogenesis (GO:0048644) | 2.89575410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.26596854 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.77684732 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.97898313 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.36379589 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.18441965 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.32398411 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.18531976 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.12291768 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.00655495 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.99868514 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.84878136 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.23936644 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.04298009 |
| 14 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.94599321 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.90621681 |
| 16 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.67823427 |
| 17 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.67823427 |
| 18 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.67616467 |
| 19 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.66573863 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64442343 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.55888936 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55407829 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54832863 |
| 24 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.50052514 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49259705 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47547694 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47266117 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46681746 |
| 29 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.44620729 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44539788 |
| 31 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.43226994 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39263743 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.37707272 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.37379496 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30897649 |
| 36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29224924 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27522629 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.27439743 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25997308 |
| 40 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24476201 |
| 41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.24303625 |
| 42 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21811267 |
| 43 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21076163 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19278465 |
| 45 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18663164 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17106340 |
| 47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16943555 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15863833 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15863833 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14307633 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13752681 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12573932 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12327113 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10730714 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.08383404 |
| 56 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.05462340 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01548738 |
| 58 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.01547184 |
| 59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.01547184 |
| 60 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00562418 |
| 61 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00552407 |
| 62 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.99785587 |
| 63 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99642264 |
| 64 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98867443 |
| 65 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98680807 |
| 66 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.98449732 |
| 67 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97857246 |
| 68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96604167 |
| 69 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.93754543 |
| 70 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93696124 |
| 71 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93646828 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93422917 |
| 73 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.93020675 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90659538 |
| 75 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.90126681 |
| 76 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.90048144 |
| 77 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89954796 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89663152 |
| 79 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.89330242 |
| 80 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88095463 |
| 81 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.87881196 |
| 82 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87648419 |
| 83 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.87055403 |
| 84 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86678715 |
| 85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86244821 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85958778 |
| 87 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.84799551 |
| 88 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84369683 |
| 89 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.84268742 |
| 90 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.84190009 |
| 91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84162778 |
| 92 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.83441179 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83081790 |
| 94 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.82763382 |
| 95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.82746873 |
| 96 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82729177 |
| 97 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.82636713 |
| 98 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82608622 |
| 99 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82377460 |
| 100 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82364086 |
| 101 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80351923 |
| 102 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.79782908 |
| 103 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77163619 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76882233 |
| 105 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.76289502 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76035850 |
| 107 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73899983 |
| 108 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.73768416 |
| 109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73045804 |
| 110 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72351101 |
| 111 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.71526760 |
| 112 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.71214013 |
| 113 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.71039568 |
| 114 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.70926442 |
| 115 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.70709975 |
| 116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70461801 |
| 117 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.69899898 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.68726346 |
| 119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68569815 |
| 120 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.68455946 |
| 121 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.68421637 |
| 122 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.68267057 |
| 123 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.67583664 |
| 124 | AR_19668381_ChIP-Seq_PC3_Human | 0.67045879 |
| 125 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66702861 |
| 126 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.66638903 |
| 127 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.65743944 |
| 128 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.65456160 |
| 129 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.65456160 |
| 130 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.64347084 |
| 131 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.63459639 |
| 132 | AR_25329375_ChIP-Seq_VCAP_Human | 0.63110640 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63055563 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.62787582 |
| 135 | CJUN_26792858_Chip-Seq_BT549_Human | 0.61998113 |
| 136 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.61316766 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60990293 |
| 138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.60253105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.62634494 |
| 2 | MP0003646_muscle_fatigue | 4.17154151 |
| 3 | MP0005360_urolithiasis | 4.12252352 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.11661617 |
| 5 | MP0000751_myopathy | 3.71024887 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.59237521 |
| 7 | MP0000749_muscle_degeneration | 3.43229092 |
| 8 | MP0005365_abnormal_bile_salt | 3.35640439 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.34791677 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.99855095 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.90122172 |
| 12 | * MP0004130_abnormal_muscle_cell | 2.81264811 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.49732128 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.44475701 |
| 15 | MP0004215_abnormal_myocardial_fiber | 2.42928781 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.38663309 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.35923583 |
| 18 | MP0000747_muscle_weakness | 2.34278386 |
| 19 | MP0005330_cardiomyopathy | 2.33300876 |
| 20 | MP0005620_abnormal_muscle_contractility | 2.31606905 |
| 21 | MP0002269_muscular_atrophy | 2.25128414 |
| 22 | MP0003252_abnormal_bile_duct | 2.21041145 |
| 23 | MP0002106_abnormal_muscle_physiology | 2.19815432 |
| 24 | MP0009840_abnormal_foam_cell | 1.92440017 |
| 25 | MP0005670_abnormal_white_adipose | 1.87837100 |
| 26 | MP0000759_abnormal_skeletal_muscle | 1.87544971 |
| 27 | MP0005332_abnormal_amino_acid | 1.86061768 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.85873285 |
| 29 | MP0005369_muscle_phenotype | 1.84382136 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.81952805 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.79113103 |
| 32 | MP0005083_abnormal_biliary_tract | 1.69567651 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.67788696 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.66753461 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.60500730 |
| 36 | MP0003195_calcinosis | 1.59908287 |
| 37 | MP0003137_abnormal_impulse_conducting | 1.59547846 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.57329901 |
| 39 | * MP0002118_abnormal_lipid_homeostasis | 1.55575443 |
| 40 | MP0008775_abnormal_heart_ventricle | 1.51946932 |
| 41 | MP0005385_cardiovascular_system_phenoty | 1.48160462 |
| 42 | MP0001544_abnormal_cardiovascular_syste | 1.48160462 |
| 43 | MP0004233_abnormal_muscle_weight | 1.45413151 |
| 44 | MP0002971_abnormal_brown_adipose | 1.43875075 |
| 45 | MP0010630_abnormal_cardiac_muscle | 1.39192791 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.35211895 |
| 47 | MP0006138_congestive_heart_failure | 1.30582007 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.29095232 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.28081131 |
| 50 | MP0004484_altered_response_of | 1.27791190 |
| 51 | MP0005275_abnormal_skin_tensile | 1.27194704 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.24366156 |
| 53 | MP0000609_abnormal_liver_physiology | 1.23676001 |
| 54 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.20177354 |
| 55 | MP0002108_abnormal_muscle_morphology | 1.16119820 |
| 56 | MP0003221_abnormal_cardiomyocyte_apopto | 1.13068344 |
| 57 | MP0005503_abnormal_tendon_morphology | 1.12357853 |
| 58 | MP0004085_abnormal_heartbeat | 1.07933624 |
| 59 | MP0005266_abnormal_metabolism | 1.05403252 |
| 60 | MP0006035_abnormal_mitochondrial_morpho | 1.05393555 |
| 61 | MP0009384_cardiac_valve_regurgitation | 1.05135662 |
| 62 | MP0005375_adipose_tissue_phenotype | 1.03843849 |
| 63 | MP0004272_abnormal_basement_membrane | 1.01819114 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 0.99683574 |
| 65 | MP0001299_abnormal_eye_distance/ | 0.98925747 |
| 66 | MP0002127_abnormal_cardiovascular_syste | 0.96885016 |
| 67 | MP0001958_emphysema | 0.96027640 |
| 68 | * MP0002078_abnormal_glucose_homeostasis | 0.94353914 |
| 69 | MP0003690_abnormal_glial_cell | 0.91979389 |
| 70 | MP0003950_abnormal_plasma_membrane | 0.90919648 |
| 71 | MP0005535_abnormal_body_temperature | 0.90808961 |
| 72 | MP0005334_abnormal_fat_pad | 0.89260664 |
| 73 | MP0000013_abnormal_adipose_tissue | 0.85778126 |
| 74 | MP0003941_abnormal_skin_development | 0.81384537 |
| 75 | MP0003279_aneurysm | 0.81035928 |
| 76 | MP0003868_abnormal_feces_composition | 0.80498507 |
| 77 | MP0010030_abnormal_orbit_morphology | 0.80399612 |
| 78 | MP0004043_abnormal_pH_regulation | 0.77954877 |
| 79 | MP0003329_amyloid_beta_deposits | 0.77947564 |
| 80 | MP0010368_abnormal_lymphatic_system | 0.77839068 |
| 81 | MP0000230_abnormal_systemic_arterial | 0.76698740 |
| 82 | MP0000762_abnormal_tongue_morphology | 0.75403336 |
| 83 | MP0004134_abnormal_chest_morphology | 0.74716617 |
| 84 | MP0005451_abnormal_body_composition | 0.74289883 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.73910439 |
| 86 | MP0002822_catalepsy | 0.73542898 |
| 87 | MP0009250_abnormal_appendicular_skeleto | 0.72363329 |
| 88 | * MP0000266_abnormal_heart_morphology | 0.69415293 |
| 89 | MP0003045_fibrosis | 0.69254598 |
| 90 | MP0002896_abnormal_bone_mineralization | 0.67580888 |
| 91 | MP0004019_abnormal_vitamin_homeostasis | 0.65395606 |
| 92 | MP0002128_abnormal_blood_circulation | 0.64062835 |
| 93 | MP0009697_abnormal_copulation | 0.63919574 |
| 94 | MP0003879_abnormal_hair_cell | 0.63673454 |
| 95 | MP0009115_abnormal_fat_cell | 0.63670557 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.63635194 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.63164829 |
| 98 | MP0001764_abnormal_homeostasis | 0.61601498 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.61525368 |
| 100 | MP0004270_analgesia | 0.61327436 |
| 101 | MP0000733_abnormal_muscle_development | 0.59755537 |
| 102 | MP0002254_reproductive_system_inflammat | 0.59151697 |
| 103 | MP0003011_delayed_dark_adaptation | 0.58263061 |
| 104 | MP0000604_amyloidosis | 0.58256809 |
| 105 | MP0005165_increased_susceptibility_to | 0.57752886 |
| 106 | MP0003828_pulmonary_edema | 0.57067747 |
| 107 | MP0005647_abnormal_sex_gland | 0.56591311 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.55933991 |
| 109 | MP0001661_extended_life_span | 0.55444869 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.55190168 |
| 111 | MP0005595_abnormal_vascular_smooth | 0.54929132 |
| 112 | MP0005448_abnormal_energy_balance | 0.54426370 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.51725938 |
| 114 | MP0003075_altered_response_to | 0.51602085 |
| 115 | MP0000343_altered_response_to | 0.51012076 |
| 116 | MP0004510_myositis | 0.50078450 |
| 117 | MP0003186_abnormal_redox_activity | 0.49718925 |
| 118 | MP0000579_abnormal_nail_morphology | 0.49082621 |
| 119 | MP0000767_abnormal_smooth_muscle | 0.42764869 |
| 120 | MP0002114_abnormal_axial_skeleton | 0.42053393 |
| 121 | MP0001542_abnormal_bone_strength | 0.41311216 |
| 122 | MP0005187_abnormal_penis_morphology | 0.39545873 |
| 123 | MP0004858_abnormal_nervous_system | 0.38313270 |
| 124 | MP0008569_lethality_at_weaning | 0.38295821 |
| 125 | MP0004142_abnormal_muscle_tone | 0.36425695 |
| 126 | MP0002249_abnormal_larynx_morphology | 0.31595572 |
| 127 | MP0009672_abnormal_birth_weight | 0.31399874 |
| 128 | MP0001879_abnormal_lymphatic_vessel | 0.31054667 |
| 129 | MP0005623_abnormal_meninges_morphology | 0.30734104 |
| 130 | MP0003385_abnormal_body_wall | 0.28668350 |
| 131 | MP0003948_abnormal_gas_homeostasis | 0.28318327 |
| 132 | MP0002734_abnormal_mechanical_nocicepti | 0.26259495 |
| 133 | MP0005452_abnormal_adipose_tissue | 0.26057588 |
| 134 | MP0002638_abnormal_pupillary_reflex | 0.24964094 |
| 135 | MP0003942_abnormal_urinary_system | 0.23419797 |
| 136 | MP0001943_abnormal_respiration | 0.23105513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.68576819 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 6.11034781 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 5.33406267 |
| 4 | Myoglobinuria (HP:0002913) | 5.24073054 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.07947068 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.59191436 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 4.57734997 |
| 8 | Nemaline bodies (HP:0003798) | 4.50624328 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.45496235 |
| 10 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.33342717 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 4.10676851 |
| 12 | Sudden death (HP:0001699) | 4.05132793 |
| 13 | Muscle fiber splitting (HP:0003555) | 3.96728415 |
| 14 | Rhabdomyolysis (HP:0003201) | 3.91902090 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 3.81872257 |
| 16 | Distal lower limb muscle weakness (HP:0009053) | 3.74062222 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 3.70396486 |
| 18 | Difficulty running (HP:0009046) | 3.64293801 |
| 19 | Deep venous thrombosis (HP:0002625) | 3.63442879 |
| 20 | Xanthomatosis (HP:0000991) | 3.57861889 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.56272201 |
| 22 | Muscle stiffness (HP:0003552) | 3.53535809 |
| 23 | Ketosis (HP:0001946) | 3.46783534 |
| 24 | Distal arthrogryposis (HP:0005684) | 3.44624089 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 3.43871610 |
| 26 | Hyperlipoproteinemia (HP:0010980) | 3.43335819 |
| 27 | Ketoacidosis (HP:0001993) | 3.42805411 |
| 28 | EMG: myopathic abnormalities (HP:0003458) | 3.42504945 |
| 29 | Hypolipoproteinemia (HP:0010981) | 3.34586513 |
| 30 | Hyperammonemia (HP:0001987) | 3.29772270 |
| 31 | Round ear (HP:0100830) | 3.25198916 |
| 32 | Hyperglycinuria (HP:0003108) | 3.14284552 |
| 33 | Increased connective tissue (HP:0009025) | 3.12051531 |
| 34 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.10297741 |
| 35 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.07775526 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.03118273 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 3.01809454 |
| 38 | Hypobetalipoproteinemia (HP:0003563) | 3.00378657 |
| 39 | Subaortic stenosis (HP:0001682) | 2.98539559 |
| 40 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.98539559 |
| 41 | Myopathic facies (HP:0002058) | 2.98485258 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.98091674 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 2.98091674 |
| 44 | Ventricular tachycardia (HP:0004756) | 2.97336319 |
| 45 | EMG: neuropathic changes (HP:0003445) | 2.94292063 |
| 46 | Myotonia (HP:0002486) | 2.94175123 |
| 47 | Hyperglycinemia (HP:0002154) | 2.90539968 |
| 48 | Complement deficiency (HP:0004431) | 2.85924419 |
| 49 | Slender build (HP:0001533) | 2.84436192 |
| 50 | Malignant hyperthermia (HP:0002047) | 2.82984942 |
| 51 | Generalized muscle weakness (HP:0003324) | 2.74126941 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.70336758 |
| 53 | Prolonged partial thromboplastin time (HP:0003645) | 2.69604654 |
| 54 | Spinal rigidity (HP:0003306) | 2.67001419 |
| 55 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.66587979 |
| 56 | Ulnar deviation of the wrist (HP:0003049) | 2.65175261 |
| 57 | Epidermoid cyst (HP:0200040) | 2.62051057 |
| 58 | Increased variability in muscle fiber diameter (HP:0003557) | 2.58730691 |
| 59 | Right ventricular cardiomyopathy (HP:0011663) | 2.58252393 |
| 60 | Lipoatrophy (HP:0100578) | 2.57816316 |
| 61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.56564709 |
| 62 | Distal lower limb amyotrophy (HP:0008944) | 2.51631210 |
| 63 | Scapular winging (HP:0003691) | 2.48726183 |
| 64 | Atrial fibrillation (HP:0005110) | 2.43311111 |
| 65 | Gowers sign (HP:0003391) | 2.43131043 |
| 66 | Absent phalangeal crease (HP:0006109) | 2.42238958 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.41242623 |
| 68 | Dicarboxylic aciduria (HP:0003215) | 2.41242623 |
| 69 | Fetal akinesia sequence (HP:0001989) | 2.38682893 |
| 70 | Hip contracture (HP:0003273) | 2.38655670 |
| 71 | Cholelithiasis (HP:0001081) | 2.34868557 |
| 72 | Bulbar palsy (HP:0001283) | 2.34584998 |
| 73 | Atrioventricular block (HP:0001678) | 2.33351953 |
| 74 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.32683163 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.31501889 |
| 76 | Heart block (HP:0012722) | 2.30904584 |
| 77 | Abnormality of the calcaneus (HP:0008364) | 2.30540002 |
| 78 | Limb-girdle muscle atrophy (HP:0003797) | 2.30358431 |
| 79 | Dilated cardiomyopathy (HP:0001644) | 2.29952482 |
| 80 | Palpitations (HP:0001962) | 2.25167551 |
| 81 | Primary atrial arrhythmia (HP:0001692) | 2.23877735 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.22700121 |
| 83 | Bundle branch block (HP:0011710) | 2.19364322 |
| 84 | Ventricular arrhythmia (HP:0004308) | 2.18914694 |
| 85 | Cerebral edema (HP:0002181) | 2.18442404 |
| 86 | Skin nodule (HP:0200036) | 2.18281447 |
| 87 | Metabolic acidosis (HP:0001942) | 2.16545563 |
| 88 | Abnormal finger flexion creases (HP:0006143) | 2.16093011 |
| 89 | Syncope (HP:0001279) | 2.16055460 |
| 90 | Hyperglycemia (HP:0003074) | 2.15632181 |
| 91 | Muscular dystrophy (HP:0003560) | 2.14752211 |
| 92 | Abnormal atrioventricular conduction (HP:0005150) | 2.12859198 |
| 93 | Neck muscle weakness (HP:0000467) | 2.11982415 |
| 94 | Gout (HP:0001997) | 2.11529081 |
| 95 | Supraventricular tachycardia (HP:0004755) | 2.10977954 |
| 96 | Rimmed vacuoles (HP:0003805) | 2.10605799 |
| 97 | Abnormality of the neuromuscular junction (HP:0003398) | 2.09948701 |
| 98 | Fatigable weakness (HP:0003473) | 2.09948701 |
| 99 | Weak cry (HP:0001612) | 2.09368674 |
| 100 | Calcaneovalgus deformity (HP:0001848) | 2.07482392 |
| 101 | Hyperkalemia (HP:0002153) | 2.07229378 |
| 102 | Supraventricular arrhythmia (HP:0005115) | 2.06243641 |
| 103 | Abnormality of serum amino acid levels (HP:0003112) | 2.05386994 |
| 104 | Proximal amyotrophy (HP:0007126) | 2.04629642 |
| 105 | Abnormality of the foot musculature (HP:0001436) | 2.04342628 |
| 106 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.99857173 |
| 107 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.98791113 |
| 108 | Waddling gait (HP:0002515) | 1.98331286 |
| 109 | Lower limb amyotrophy (HP:0007210) | 1.97234994 |
| 110 | Areflexia of lower limbs (HP:0002522) | 1.96449792 |
| 111 | Hypoglycemic seizures (HP:0002173) | 1.94900978 |
| 112 | Abnormality of the common coagulation pathway (HP:0010990) | 1.94745051 |
| 113 | Difficulty climbing stairs (HP:0003551) | 1.94606544 |
| 114 | Progressive muscle weakness (HP:0003323) | 1.94003861 |
| 115 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.93598033 |
| 116 | Hypercholesterolemia (HP:0003124) | 1.92326866 |
| 117 | Deformed tarsal bones (HP:0008119) | 1.92081170 |
| 118 | Increased purine levels (HP:0004368) | 1.92080148 |
| 119 | Hyperuricemia (HP:0002149) | 1.92080148 |
| 120 | Abnormality of methionine metabolism (HP:0010901) | 1.91679662 |
| 121 | Foot dorsiflexor weakness (HP:0009027) | 1.90451718 |
| 122 | Prolonged QT interval (HP:0001657) | 1.89582870 |
| 123 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.89085304 |
| 124 | Limited hip movement (HP:0008800) | 1.89008265 |
| 125 | Lethargy (HP:0001254) | 1.88331356 |
| 126 | Abnormality of the Achilles tendon (HP:0005109) | 1.88255224 |
| 127 | Abnormality of purine metabolism (HP:0004352) | 1.87218502 |
| 128 | Frequent falls (HP:0002359) | 1.86820761 |
| 129 | Limb-girdle muscle weakness (HP:0003325) | 1.86643413 |
| 130 | Late onset (HP:0003584) | 1.86499431 |
| 131 | Metatarsus adductus (HP:0001840) | 1.83814230 |
| 132 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.81359376 |
| 133 | Popliteal pterygium (HP:0009756) | 1.75282690 |
| 134 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.69430109 |
| 135 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.69430109 |
| 136 | Ulnar deviation of finger (HP:0009465) | 1.66868170 |
| 137 | Facial diplegia (HP:0001349) | 1.60736625 |
| 138 | Protrusio acetabuli (HP:0003179) | 1.56201082 |
| 139 | Long clavicles (HP:0000890) | 1.55542647 |
| 140 | Ragged-red muscle fibers (HP:0003200) | 1.55251947 |
| 141 | Shoulder girdle muscle weakness (HP:0003547) | 1.52622639 |
| 142 | Steppage gait (HP:0003376) | 1.51312617 |
| 143 | Pelvic girdle muscle weakness (HP:0003749) | 1.49564751 |
| 144 | Aortic aneurysm (HP:0004942) | 1.48950082 |
| 145 | Exercise intolerance (HP:0003546) | 1.48599299 |
| 146 | Breech presentation (HP:0001623) | 1.46223150 |
| 147 | Nonprogressive disorder (HP:0003680) | 1.42997406 |
| 148 | Oligomenorrhea (HP:0000876) | 1.41488003 |
| 149 | Generalized amyotrophy (HP:0003700) | 1.38151707 |
| 150 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.38062923 |
| 151 | Achilles tendon contracture (HP:0001771) | 1.37391142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.79639045 |
| 2 | PHKG2 | 4.57846882 |
| 3 | PHKG1 | 4.57846882 |
| 4 | TTN | 3.98580802 |
| 5 | BCKDK | 3.61443188 |
| 6 | TRIB3 | 3.14818694 |
| 7 | SIK1 | 2.41183859 |
| 8 | PDK3 | 2.40083492 |
| 9 | PDK4 | 2.40083492 |
| 10 | PKN2 | 2.37077695 |
| 11 | PINK1 | 2.17437884 |
| 12 | NEK1 | 2.00569543 |
| 13 | PIK3CG | 2.00494657 |
| 14 | LMTK2 | 1.97686167 |
| 15 | MAP3K7 | 1.88118792 |
| 16 | MUSK | 1.80902470 |
| 17 | INSRR | 1.79577423 |
| 18 | MAP2K4 | 1.76682070 |
| 19 | PIK3CA | 1.76628864 |
| 20 | DMPK | 1.69969451 |
| 21 | MAPK12 | 1.52164700 |
| 22 | NME1 | 1.49932907 |
| 23 | LIMK1 | 1.38463551 |
| 24 | PDK2 | 1.36298805 |
| 25 | TRPM7 | 1.32368423 |
| 26 | MAP2K3 | 1.27201047 |
| 27 | EPHA4 | 1.26881872 |
| 28 | LATS1 | 1.22310418 |
| 29 | PRKAA2 | 1.20601080 |
| 30 | ERN1 | 1.18175202 |
| 31 | MARK1 | 1.14584370 |
| 32 | FGFR4 | 1.14124392 |
| 33 | RIPK1 | 1.10419313 |
| 34 | MYLK | 1.06518753 |
| 35 | MOS | 1.03520439 |
| 36 | MAPK11 | 1.00142495 |
| 37 | NEK9 | 0.98728352 |
| 38 | EEF2K | 0.96544184 |
| 39 | STK24 | 0.93764188 |
| 40 | TIE1 | 0.93698106 |
| 41 | * PRKAA1 | 0.85642393 |
| 42 | CAMK2G | 0.81056110 |
| 43 | PAK3 | 0.80096775 |
| 44 | FLT3 | 0.80021969 |
| 45 | ERBB3 | 0.78284401 |
| 46 | DYRK1B | 0.76002346 |
| 47 | STK38 | 0.73389078 |
| 48 | PTK6 | 0.70436431 |
| 49 | SGK3 | 0.70144512 |
| 50 | STK38L | 0.68820014 |
| 51 | CAMK1D | 0.67784512 |
| 52 | ERBB4 | 0.66874004 |
| 53 | CCNB1 | 0.66495632 |
| 54 | ROCK1 | 0.64324488 |
| 55 | MAP3K4 | 0.62555059 |
| 56 | CAMK2D | 0.62117958 |
| 57 | MAP2K6 | 0.61327081 |
| 58 | CAMK1G | 0.60718196 |
| 59 | SGK2 | 0.60444394 |
| 60 | PRKD1 | 0.60186545 |
| 61 | MAP3K5 | 0.59144300 |
| 62 | MAP3K3 | 0.58088207 |
| 63 | PRKD3 | 0.57656401 |
| 64 | PDGFRA | 0.56040159 |
| 65 | TAOK2 | 0.55765230 |
| 66 | FGFR2 | 0.55725831 |
| 67 | DAPK2 | 0.54778385 |
| 68 | AKT3 | 0.54263458 |
| 69 | PRKACG | 0.53440074 |
| 70 | PAK6 | 0.52808179 |
| 71 | CAMK2B | 0.52727863 |
| 72 | LATS2 | 0.52132495 |
| 73 | PDPK1 | 0.51966971 |
| 74 | FGFR3 | 0.51538603 |
| 75 | PKN1 | 0.50856035 |
| 76 | RET | 0.50240833 |
| 77 | KSR2 | 0.49728311 |
| 78 | ILK | 0.49038866 |
| 79 | MAPK7 | 0.48617344 |
| 80 | DDR2 | 0.48457554 |
| 81 | ICK | 0.46971437 |
| 82 | AKT2 | 0.46865629 |
| 83 | PDK1 | 0.43106679 |
| 84 | CAMK2A | 0.43040575 |
| 85 | SGK494 | 0.41981531 |
| 86 | SGK223 | 0.41981531 |
| 87 | CAMK4 | 0.41009634 |
| 88 | JAK2 | 0.39692753 |
| 89 | EPHB1 | 0.39269105 |
| 90 | PRKACB | 0.39195491 |
| 91 | SGK1 | 0.38979122 |
| 92 | JAK1 | 0.38746484 |
| 93 | CAMKK1 | 0.38740640 |
| 94 | ZAK | 0.38679748 |
| 95 | RPS6KA3 | 0.38523889 |
| 96 | NTRK2 | 0.38399557 |
| 97 | FGFR1 | 0.38150843 |
| 98 | PRKACA | 0.37716720 |
| 99 | MAPK4 | 0.36593638 |
| 100 | PRKCH | 0.36422642 |
| 101 | MAP2K1 | 0.35722402 |
| 102 | FER | 0.35631690 |
| 103 | MET | 0.34721575 |
| 104 | PRKG1 | 0.34274521 |
| 105 | MAPKAPK3 | 0.34242511 |
| 106 | MAP3K13 | 0.34029299 |
| 107 | TGFBR2 | 0.32376983 |
| 108 | CDC42BPA | 0.30550105 |
| 109 | MST1R | 0.29811654 |
| 110 | CAMK1 | 0.29179885 |
| 111 | MAP3K6 | 0.28755584 |
| 112 | PRKCG | 0.27380666 |
| 113 | NTRK3 | 0.26917072 |
| 114 | MTOR | 0.26525385 |
| 115 | DAPK3 | 0.25860657 |
| 116 | PTK2B | 0.25794096 |
| 117 | RPS6KB1 | 0.24956093 |
| 118 | MAPK10 | 0.24060003 |
| 119 | ARAF | 0.23461525 |
| 120 | ROCK2 | 0.23457092 |
| 121 | PAK2 | 0.21144751 |
| 122 | GRK7 | 0.20937429 |
| 123 | PTK2 | 0.20885215 |
| 124 | RAF1 | 0.19865592 |
| 125 | RPS6KL1 | 0.18633875 |
| 126 | RPS6KC1 | 0.18633875 |
| 127 | RPS6KB2 | 0.16554472 |
| 128 | EPHA3 | 0.16176387 |
| 129 | RPS6KA1 | 0.16026814 |
| 130 | MARK2 | 0.16023442 |
| 131 | WNK1 | 0.13772020 |
| 132 | MAP3K1 | 0.13207297 |
| 133 | MAP3K9 | 0.12508671 |
| 134 | RPS6KA6 | 0.12503134 |
| 135 | NTRK1 | 0.12325682 |
| 136 | RPS6KA2 | 0.12072267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.17884169 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28548177 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.13951360 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.04036191 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.90885598 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.88635564 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.84124669 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.73831544 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.64486439 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52332344 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.43875135 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.09499086 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07179565 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.05450825 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.01107495 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.89361549 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.84477016 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.72603157 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.70884694 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.69658678 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67945429 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67045944 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.66403348 |
| 24 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.52805036 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48431939 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.46255423 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44270358 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.38005505 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38004157 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.35877950 |
| 31 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.31040228 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29920329 |
| 33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.27490941 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.24297038 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.17646184 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14968030 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13593146 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11751271 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 1.10150306 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09828513 |
| 41 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.05015143 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.01133378 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00378693 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98741253 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97901714 |
| 46 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97721594 |
| 47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.95266072 |
| 48 | Tight junction_Homo sapiens_hsa04530 | 0.95082183 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92519699 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91905533 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90623439 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87576378 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86599254 |
| 54 | * Insulin resistance_Homo sapiens_hsa04931 | 0.86231057 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85494829 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.84218838 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82693871 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82245222 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78616479 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73853439 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.69755970 |
| 62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66631613 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66130757 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63459125 |
| 65 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62924520 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62667513 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62609845 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62457174 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62265631 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61562213 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61451480 |
| 72 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61133873 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60175759 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59136474 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57525846 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57151564 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54612154 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.48981347 |
| 79 | Adherens junction_Homo sapiens_hsa04520 | 0.48274109 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47845533 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46618974 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45569423 |
| 83 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43343407 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42733042 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42232766 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41126087 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39990206 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.39567386 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39300479 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37833412 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36987235 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35734323 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35019046 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34314359 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33938853 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33492309 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.33121569 |
| 98 | Gap junction_Homo sapiens_hsa04540 | 0.32677288 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32561233 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31387946 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31230122 |
| 102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31130342 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31080404 |
| 104 | Long-term depression_Homo sapiens_hsa04730 | 0.29423824 |
| 105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28577709 |
| 106 | Insulin secretion_Homo sapiens_hsa04911 | 0.28561138 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.28548524 |
| 108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27886955 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27578600 |
| 110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27326425 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27149588 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26957612 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25910832 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25752657 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24680169 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.24272122 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23493345 |
| 118 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23431839 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.23323908 |
| 120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.22982122 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.21472846 |
| 122 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.21171887 |
| 123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.20474016 |
| 124 | GABAergic synapse_Homo sapiens_hsa04727 | 0.20351956 |
| 125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.20133607 |
| 126 | Renin secretion_Homo sapiens_hsa04924 | 0.18894416 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.15818705 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.14574390 |
| 129 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10820398 |
| 130 | Circadian entrainment_Homo sapiens_hsa04713 | 0.09583697 |

